Edition:
United States

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

154.72USD
4:02pm EDT
Change (% chg)

$0.76 (+0.49%)
Prev Close
$153.96
Open
$153.23
Day's High
$155.09
Day's Low
$151.75
Volume
123,774
Avg. Vol
214,074
52-wk High
$190.35
52-wk Low
$119.38

Latest Key Developments (Source: Significant Developments)

LabCorp, Envigo Sign Agreement To Expand Covance's Nonclinical Drug Development Capabilities
Wednesday, 17 Apr 2019 05:05pm EDT 

April 17 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP AND ENVIGO SIGN INNOVATIVE AGREEMENT TO EXPAND COVANCE’S NONCLINICAL DRUG DEVELOPMENT CAPABILITIES AND CREATE AN INDEPENDENT RESEARCH MODELS PROVIDER.LABCORP - PROPOSED TRANSACTIONS WILL RESULT IN NET IMPLIED CASH CONSIDERATION TO BE PAID BY LABCORP OF $485 MILLION.LABCORP - NET IMPACT OF PROPOSED TRANSACTIONS WILL BE AN INCREMENTAL $156 MILLION IN LABCORP'S REVENUES ON A PRO FORMA 2018 BASIS.LABCORP - PROPOSED TRANSACTIONS ARE EXPECTED TO MEET LABCORP'S FINANCIAL CRITERIA OF EARNINGS AND CASH ACCRETION IN YEAR ONE.LABCORP - LABCORP WILL PURCHASE ENVIGO'S NONCLINICAL CONTRACT RESEARCH SERVICES BUSINESS.LABCORP - ENVIGO'S RESEARCH MODELS AND SERVICES BUSINESS WILL PURCHASE COVANCE'S RESEARCH PRODUCTS BUSINESS LOCATED IN UNITED STATES.LABCORP - COVANCE AND NEW ENVIGO RESEARCH MODELS AND SERVICES ENTITY WILL ENTER INTO A MULTI-YEAR RENEWABLE SUPPLY AGREEMENT.  Full Article

Qiagen And LabCorp Launch Collaboration For Companion Diagnostics Access
Wednesday, 3 Apr 2019 04:00pm EDT 

April 3 (Reuters) - Laboratory Corporation of America Holdings ::QIAGEN AND LABCORP LAUNCH COLLABORATION TO PROVIDE DAY-ONE ACCESS FOR PATIENTS TO INNOVATIVE COMPANION DIAGNOSTICS AT TIME OF DRUG APPROVALS.  Full Article

Labcorp And Texas Association Of Community Health Centers Extend Agreement For Labcorp To Be Exclusive Laboratory
Tuesday, 15 Jan 2019 08:48am EST 

Jan 15 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP AND TEXAS ASSOCIATION OF COMMUNITY HEALTH CENTERS EXTEND AGREEMENT FOR LABCORP TO BE EXCLUSIVE LABORATORY FOR COMMUNITY HEALTH CENTERS ACROSS TEXAS.LABCORP - TACHC INTENDS TO MAKE LABCORP'S LITHOLINK CLINICAL DECISION SUPPORT PROGRAMS AVAILABLE TO ITS MEMBERS.  Full Article

Labcorp Sees 2018 Adj EPS Of $10.95 To $11.05
Friday, 30 Nov 2018 06:56am EST 

Nov 30 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP UPDATES FULL-YEAR 2018 GUIDANCE.LABCORP SEES 2018 ADJUSTED EPS $10.95 TO $11.05.LABCORP - SEES FY TOTAL REVENUE GROWTH 9.9% TO 10.3%.LABCORP SEES FY ADJUSTED EPS $10.95 TO $11.05.LABCORP SEES 2018 FREE CASH FLOW $940 MILLION TO $980 MILLION.LABCORP - LOOKING TO NEXT YEAR, CONTINUE TO EXPECT MODEST EPS GROWTH OVER UPDATED 2018 EARNINGS.LABCORP - COST REDUCTION INITIATIVES STATED IN Q3 CALL, WILL BE INSUFFICIENT TO MAINTAIN PRIOR OUTLOOK IN LIGHT OF UNANTICIPATED VOLUME SHORTFALL.LABCORP - REVISED OUTLOOK DRIVEN BY LOWER-THAN-EXPECTED VOLUME GROWTH IN LABCORP DIAGNOSTICS, WHICH CO BELIEVES WILL CONTINUE FOR REMAINDER OF YEAR.LABCORP - CONTINUE TO BE CONFIDENT IN OUTLOOK IN COVANCE DRUG DEVELOPMENT.FY2018 EARNINGS PER SHARE VIEW $11.35, REVENUE VIEW $11.39 BILLION -- REFINITIV IBES DATA.LABCORP - SOFTNESS IN DEMAND PRIMARILY DUE TO SLOWER GROWTH IN REFERRED DIRECT-TO-CONSUMER GENETIC TESTING, ADVERSE WEATHER, OTHERS.  Full Article

LabCorp At Walgreens Expands Into Southern California
Wednesday, 28 Nov 2018 08:45am EST 

Nov 28 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP AT WALGREENS EXPANDS INTO SOUTHERN CALIFORNIA.  Full Article

Labcorp Reports Q3 Adj EPS Of $2.74
Wednesday, 24 Oct 2018 06:50am EDT 

Oct 24 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP ANNOUNCES 2018 THIRD QUARTER RESULTS AND UPDATES 2018 GUIDANCE.Q3 EARNINGS PER SHARE $3.10.Q3 REVENUE $2.83 BILLION VERSUS I/B/E/S VIEW $2.84 BILLION.Q3 EARNINGS PER SHARE VIEW $2.88 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $11.25 TO $11.45.Q3 ADJUSTED EARNINGS PER SHARE $2.74.LABCORP - 2018 FREE CASH FLOW GUIDANCE OF $975 MILLION TO $1,025 MILLION.SEES FY18 REVENUE GROWTH OF 10.5% TO 11.0% OVER 2017 REVENUE OF $10.31 BILLION.BACKLOG AT QUARTER-END FOR COVANCE DRUG DEVELOPMENT WAS $9.40 BILLION COMPARED TO $8.97 BILLION LAST QUARTER.FY2018 EARNINGS PER SHARE VIEW $11.53 -- THOMSON REUTERS I/B/E/S.  Full Article

Labcorp Issued Statement On District Court Opinion In Acla Lawsuit Against HHS
Monday, 24 Sep 2018 07:10am EDT 

Sept 24 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP STATEMENT ON DISTRICT COURT OPINION IN ACLA LAWSUIT AGAINST HHS.LABCORP - ISSUED STATEMENT REGARDING COURT DECISION TO DISMISS LAWSUIT TO HALT IMPLEMENTATION OF DAMAGING CUTS TO MEDICARE REIMBURSEMENT FOR LAB TESTING.LABCORP - EVALUATING OPTIONS ALONGSIDE INDUSTRY ASSOCIATION ACLA & COLLEAGUES TO "HELP PROTECT MEDICARE BENEFICIARIES' CONTINUED ACCESS TO NEEDED LAB TESTING".  Full Article

LabCorp Launches Proprietary UltraQual Multiplex PCR Assay For HCV, HIV-1, HIV-2 And HBV
Wednesday, 27 Jun 2018 08:45am EDT 

June 27 (Reuters) - Laboratory Corporation of America Holdings ::LABCORP LAUNCHES PROPRIETARY ULTRAQUAL® MULTIPLEX PCR ASSAY FOR HCV, HIV-1, HIV-2 AND HBV.LABCORP - RECEIVED APPROVAL FROM U.S. FDA FOR ULTRAQUAL MULTIPLEX PCR ASSAY FOR HCV, HIV-1, HIV-2 AND HBV FOR SCREENING OF DONATED BLOOD PLASMA.  Full Article

UnitedHealthcare Renewed Strategic Partnership With LabCorp
Thursday, 24 May 2018 04:30pm EDT 

May 24 (Reuters) - Laboratory Corporation of America Holdings ::UNITEDHEALTHCARE ESTABLISHES LONG-TERM STRATEGIC PARTNERSHIP WITH LABCORP.LABCORP - CO, UNITEDHEALTHCARE HAVE RENEWED THEIR LONG-TERM STRATEGIC PARTNERSHIP.  Full Article

Eurofins Scientific Acquires LabCorp's Food Testing And Consulting Business
Monday, 30 Apr 2018 01:46am EDT 

April 30 (Reuters) - EUROFINS SCIENTIFIC SE ::ACQUISITION OF LABCORP’S FOOD TESTING AND CONSULTING BUSINESS.TRANSACTION EXPECTED TO CLOSE IN Q3 OF 2018.AGREED ACQUISITION PRICE IS US$670M ON A CASH FREE DEBT FREE BASIS.  Full Article